Dr. Nabeel N Farooqui, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 11501 Cumberland Rd Ste 500, Fishers, IN 46037 Phone: 317-863-9300 Fax: 317-863-9333 |
News Archive
Stroke survivors who have an irregular heartbeat called atrial fibrillation may be at higher risk of developing dementia than stroke survivors who do not have the heart condition, according to research published in the March 8, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Today, the No on 46 campaign released its first campaign video on multiple online platforms. Entitled "The Truth about Proposition 46," the two-minute video features real practicing physicians and medical students from across the state discussing the flaws, costs and potential harmful consequences to patients and California's health care system, if 46 were to pass.
Repros Therapeutics Inc. today announced that a teleconference was held with the FDA to review the clinical hold status of Proellex®. Previously clinical studies were stopped due to findings of changes in liver enzymes at higher doses of the oral drug resulting in serious adverse events. Proellex is being studied as a treatment for uterine fibroids and endometriosis.
Scientists at A*STAR's Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified a new subset of dendritic cells (DCs) in human peripheral tissue which have a critical role in activating our immune response against harmful pathogens.
› Verified 1 days ago